Interactive Prototype

The clinical dashboard — live.

Navigate the prototype below. Click patients, switch panels, and explore how Polyp Point delivers AI-powered risk insights to physicians.

polyppoint.com/clinical-dashboard

Dr. Sarah Chen · USC Medical

📊 Dashboard

👥 Patients

📈 Analytics

📋 Reports

🔔 Alerts 3

Active Patients

148

↑ 12 this week

High Risk Flagged

Require follow-up

Tests Processed

312

↑ 94.2% accuracy

Avg Risk Score

18%

Low-moderate range

Recent Patients

7 flagged

Sarah M.

PP-3847 · 47F

Low

James K.

PP-3901 · 62M

Moderate

Maria L.

PP-3912 · 58F

High

Tom R.

PP-3820 · 55M

Low

Linda H.

PP-3788 · 71F

Moderate

Sarah M.

PP-3847 · 47F · Tested March 2, 2026

12%

Risk

Low Risk

Model confidence: 94.2%

Biomarker Panel

CEA Level

2.1 ng/mL ✓

Normal: <3.0

CRP

0.4 mg/L ✓

Normal: <1.0

cfDNA Methylation

Borderline ↗

Monitor closely

AI Confidence

94.2% ✓

High confidence

Clinical Recommendation

No immediate action recommended. Routine screening in 3 years.

PatientAge/SexCEARisk ScoreStatus

Monthly Tests Processed

Risk Distribution (All Patients)

Low Risk (62%)

Moderate (23%)

High Risk (15%)

Model Performance Metrics

91.4%

Sensitivity

88.7%

Specificity

84.2%

PPV

93.6%

NPV

0.941

AUC-ROC

🚨 Urgent — Maria L. (PP-3912)

High risk score of 81%. CEA elevated at 7.3 ng/mL. cfDNA methylation flagged HIGH. Urgent colonoscopy referral recommended within 4 weeks.

⚠️ Follow-Up — James K. (PP-3901)

Moderate risk at 54%. CEA borderline at 4.8. Recommend follow-up colonoscopy within 6 months or repeat Polyp Point panel in 3 months.

⚠️ Monitor — Linda H. (PP-3788)

Borderline moderate at 47%. Trending upward from last panel (38%). Recommend elective colonoscopy or 3-month repeat test.